Two new studies examining the use of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs in connection to ovarian cancer found that women could benefit from daily aspirin consumption to reduce cancer risk and improve survival after diagnosis.
The Cancer Letter has covered—and will continue to cover—all the ways in which the current administration is fundamentally reshaping cancer research in the U.S. But this week, The Cancer Letter and the podcast focused on a patient story.
